Drugs / Aolanti Weikang tablets
Aolanti Weikang tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03358485 | Dec 2017 → Apr 2018 | dyspepsia | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aolanti Weikang tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03358485 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Aolanti Weikang tablets is a Chinese patent drug designed to treat Functional dyspepsia (FD).” NCT03358485 ↗ |
| Route | Oral | “given orally Aolanti Weikang tablets” NCT03358485 ↗ |